参考文献 References
[1] Kowdley K V , Brown K E , Ahn J ,et al.ACG Clinical Guideline: Hereditary Hemochromatosis[J].The American Journal of Gastroenterology, 2019, 114(8):1.
[2] Mohamed M , Phillips J .Hereditary haemochromatosis: BMJ Practice[J].Bmj, 2016:i3128.
[3] Crownover B K , Covey C J .Hereditary hemochromatosis. [J].American Family Physician, 2013(3):87.
[4] Sandnes M , Ulvik R J , Vorland M ,et al. Hyperferritinemia —A Clinical Overview[J].Journal of Clinical Medicine, 2021, 10(9):2008.
[5] Girelli D, Busti F, Brissot P, Cabantchik I, Muckenthaler MU, Porto G. Hemochromatosis classification: update and recommendations by the BIOIRON Society. Blood. 2022; 139(20):3018-3029.
[6] Pimpin L , Cortez-Pinto H , Negro F ,et al.Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies[J]. Journal of Hepatology, 2018:S0168827818320579.
[7] Wang S , Liu Z , Geng J ,et al.An overview of ferroptosis in non-alcoholic fatty liver disease[J].Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie, 2022: 153.
[8] A J T , A D L , C H M ,et al.Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease[J].药学学报:英文版, 2022, 12(9):17.
[9] Shu YY, Gao WK, Chu HK, Yang L, Pan XL, Ye J. Attenuation by Time-Restricted Feeding of High-Fat and High-Fructose Diet-Induced NASH in Mice Is Related to Per2 and Ferroptosis. Oxid Med Cell Longev. 2022 Oct 15;2022:8063897.
[10] Luis C B , Leon A .The Natural Course of Non-Alcoholic Fatty Liver Disease[J].International Journal of Molecular Sciences, 2016, 17(5).
[11] Loomba R , Adams L .The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH.[J].Hepatology (Baltimore, Md.), 2019, 70(6):1885-1888.
[12] A M J , B H Z , A Q Q ,et al.Ferroptosis as a new therapeutic opportunity for nonviral liver disease[J].European Journal of Pharmacology, 2021.
[13] Yan H F , Zou T , Tuo Q Z ,et al.Ferroptosis: mechanisms and links with diseases[J].Signal Transduction and Targeted Therapy, 2021, 6(1):49.
[14] Chen J , Li X , Ge C ,et al.The multifaceted role of ferroptosis in liver disease[J].Cell death and differentiation, 2022(3):29.
[15] Santoro MM. The Antioxidant Role of Non-mitochondrial CoQ10: Mystery Solved! Cell Metab. 2020 Jan 7;31(1):13-15.
[16] Xu R, Wang W, Zhang W. Ferroptosis and the bidirectional regulatory factor p53. Cell Death Discov. 2023 Jun 29;9(1):197.
[17] Asrani S K , Devarbhavi H , Eaton J ,et al.Burden of liver diseases in the world[J].Journal of hepatology, 2019, 70(1):151-171.
[18] You Y, Liu C, Liu T, et al. FNDC3B protects steatosis and ferroptosis via the AMPK pathway in alcoholic fatty liver disease. Free Radic Biol Med. 2022;193(Pt 2):808-819.
[19] Chapman RW, Morgan MY, Boss AM, Sherlock S. Acute and chronic effects of alcohol on iron absorption. Dig Dis Sci. 1983 Apr;28(4):321-7.
[20] Ricardo U. Macías-Rodríguez,María Eugenia Inzaugarat, Astrid Ruiz-Margáin,et al. Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?[J].International Journal of Molecular Sciences, 2020, 21(5):1651-.
[21] Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N, Sanyal AJ, Nelson JE; NASH Clinical Research Network. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012 Jan;55(1):77-85.
[22] Fujita N, Takei Y. Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C. J Gastroenterol. 2007 Nov;42(11):923-6.
[23] Batsaikhan B, Gantumur G, Huang CI, Yeh ML, Huang CF, Lin ZY, Chen SC, Huang JF, Yu ML, Chuang WL, Lee JC, Dai CY. Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus-infected patients. J Chin Med Assoc. 2019 Feb;82(2):99-104.
[24] Sikorska K, Romanowski T, Stalke P, Izycka Swieszewska E, Bielawski KP. Association of hepcidin mRNA expression with hepatocyte iron accumulation and effects of antiviral therapy in chronic hepatitis C infection. Hepat Mon. 2014 Nov 1;14(11):e21184.
[25] Tornai D, Antal-Szalmas P, Tornai T, Papp M, Tornai I, Sipeki N, Janka T, Balogh B, Vitalis Z. Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study. BMC Gastroenterol. 2021 Mar 2;21(1):94.
[26] Shen J, Sheng X, Chang Z, Wu Q, Wang S, Xuan Z, Li D, Wu Y, Shang Y, Kong X, Yu L, Li L, Ruan K, Hu H, Huang Y, Hui L, Xie D, Wang F, Hu R. Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function. Cell Rep. 2014 Apr 10;7(1):180-93.
[27] Recalcati S, Correnti M, Gammella E, Raggi C, Invernizzi P, Cairo G. Iron Metabolism in Liver Cancer Stem Cells. Front Oncol. 2019 Mar 19;9:149.